Author: Sponsored Post

Do you want your own sponsored article to appear on our website? Contact us at workwith-at-labiotech.eu

Genotyping, outsourcing genotyping, automatic genotyping, laboratory, genomic data, Transnetyx

17/04/2019 7 mins

The Benefits of Outsourcing Your Genotyping Process

protein kinases, kinase inhibitors, white paper, cisbio

15/04/2019 <1 min

The Human Kinome: A Study of Protein Kinases & Their Therapeutic Potential

CDMOs, drug development, drug development and manufacturing partner, Eurofins Amatsigroup

10/04/2019 6 mins

The Momentum of CDMOs: What to Look Out for When Choosing a Drug Development Partner

cloning technologies, seamless cloning, Gibson Assembly, Golden Gate Assembly, In-Fusion Cloning, Takara Bio

08/04/2019 <1 min

Infographic: The Landscape of Next Generation Seamless Cloning Technologies

03/04/2019 <1 min

Infographic: The Importance of New Biological Drug Characterization

Inflammatory Bowel Disease, IBD, inflammation, mouse model, TransCure bioServices, IBD treatment

01/04/2019 6 mins

This Mouse Model is Getting Us Closer to Treating Inflammatory Bowel Disease

infographic, pediatric drug development, synteract

27/03/2019 <1 min

Infographic: Unraveling the Complexity of Pediatric Dug Development

cell lines, cell line development, Cevec, glycosylation, vaccines, gene therapy vectors

20/03/2019 9 mins

Interview: These Cell Lines Give Biopharmaceutical Development a Boost

Immune System, Syngeneic Mouse Models, Cancer, Oncology, immunotherapies, immuno-oncology

11/03/2019 10 mins

Can This Mouse Model Help Us Cure Cancer?

funding, Merck, Millipore Sigma, CDMO, partner company, cell line development, regulatory authorities, drug development

04/03/2019 10 mins

Just Got Funding? What Now?

immunotherapies, immuno-oncology, immune monitoring, immune profiling, Fluidigm, mass cytometry

27/02/2019 4 mins

Taking Immune Monitoring to a Whole New Level

25/02/2019 <1 min

White Paper: A Guide To Current Therapies in Immuno-Oncology

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and it's freely accessible content.